Idioma:

Belimumab--the biological drug for systemic lupus erythematosus: as discussed during the American College of Rheumatology (ACR) conference - 2012

Vadasz, Z ; Toubi, E

Harefuah, 2013-05, Vol.152 (5), p.304-306

Texto completo disponível

Citações Citado por

Título:
Belimumab--the biological drug for systemic lupus erythematosus: as discussed during the American College of Rheumatology (ACR) conference - 2012
Autor: Vadasz, Z ; Toubi, E
Assuntos: Antibodies, Monoclonal, Humanized - therapeutic use ; B-Cell Activating Factor - immunology ; Humans ; Immunosuppressive Agents - therapeutic use ; Lupus Erythematosus, Systemic - drug therapy ; Lupus Erythematosus, Systemic - immunology
É parte de: Harefuah, 2013-05, Vol.152 (5), p.304-306
Notas: ObjectType-Conference-1
SourceType-Conference Papers & Proceedings-1
content type line 25
Editor: Israel
Idioma: Hebraico

Links

Voltar para lista de resultados